Themis Medicare Limited (BOM:530199)
India · Delayed Price · Currency is INR 127.95
-4.05 (-3.07%)
At close: Sep 11, 2026
Themis Medicare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 11,784 | 6,067 | 13,498 | 20,157 | 10,735 | 8,585 | |
Market Cap Growth | 27.56% | -55.05% | -33.04% | 87.77% | 25.04% | 233.36% |
Enterprise Value | 12,694 | 6,895 | 14,136 | 20,879 | 11,314 | 8,996 |
Last Close Price | 127.95 | 65.87 | 145.94 | 217.46 | 115.46 | 91.79 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 30.50 | 530.35 | 45.24 | 46.31 | 18.86 | 11.78 |
Forward PE | - | 17.18 | 17.18 | 17.18 | 17.18 | 17.18 |
PS Ratio | 3.55 | 1.77 | 3.33 | 5.28 | 3.03 | 2.18 |
PB Ratio | 2.96 | 1.52 | 3.35 | 5.34 | 3.16 | 2.99 |
P/TBV Ratio | 2.96 | 1.52 | 3.36 | 5.35 | 3.17 | 3.00 |
P/FCF Ratio | - | - | 70.00 | 548.38 | - | 62.36 |
P/OCF Ratio | - | - | 38.89 | 91.23 | 66.71 | 24.96 |
PEG Ratio | - | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.83 | 2.02 | 3.49 | 5.47 | 3.19 | 2.28 |
EV/EBITDA Ratio | - | 1753.51 | 28.82 | 40.54 | 16.97 | 9.50 |
EV/EBIT Ratio | - | - | 36.14 | 53.18 | 19.86 | 10.44 |
EV/FCF Ratio | - | - | 73.31 | 568.02 | - | 65.35 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.25 | 0.25 | 0.21 | 0.25 | 0.27 | 0.28 |
Debt / EBITDA Ratio | - | 254.56 | 1.69 | 1.86 | 1.37 | 0.83 |
Debt / FCF Ratio | - | - | 4.30 | 26.06 | - | 5.79 |
Net Debt / Equity Ratio | 0.23 | 0.23 | 0.19 | 0.23 | 0.24 | 0.21 |
Net Debt / EBITDA Ratio | -2.17 | 231.29 | 1.56 | 1.67 | 1.20 | 0.63 |
Net Debt / FCF Ratio | - | -11.18 | 3.96 | 23.36 | -6.31 | 4.32 |
Asset Turnover | - | 0.58 | 0.70 | 0.71 | 0.75 | 0.99 |
Inventory Turnover | - | 1.57 | 1.73 | 1.99 | 1.86 | 2.53 |
Quick Ratio | - | 1.13 | 1.18 | 1.23 | 1.13 | 1.11 |
Current Ratio | - | 1.84 | 1.95 | 1.92 | 1.90 | 1.96 |
Return on Equity (ROE) | - | 0.29% | 7.65% | 12.14% | 18.15% | 28.81% |
Return on Assets (ROA) | - | -1.05% | 4.24% | 4.54% | 7.56% | 13.48% |
Return on Invested Capital (ROIC) | -7.82% | -1.22% | 6.24% | 7.24% | 11.67% | 20.79% |
Return on Capital Employed (ROCE) | - | -2.30% | 9.10% | 9.50% | 15.20% | 27.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.39% | 0.19% | 2.21% | 2.16% | 5.30% | 8.49% |
FCF Yield | -0.69% | -1.34% | 1.43% | 0.18% | -1.18% | 1.60% |
Dividend Yield | 0.38% | 0.76% | 0.34% | 0.23% | 0.43% | 0.55% |
Payout Ratio | - | 402.31% | 15.43% | 10.57% | 8.08% | 5.43% |
Buyback Yield / Dilution | -3.42% | -3.37% | -0.01% | -0.03% | -0.01% | -0.28% |
Total Shareholder Return | -3.04% | -2.61% | 0.33% | 0.20% | 0.43% | 0.26% |